DNTH

Biotechnology DNTH Uncategorized

Dianthus Therapeutics prices upsized $625M public offering at $81/share

Mar 11, 2026

Biotechnology DNTH SAN:CA SNY SNY:CA SNYNF Terry Chrisomalis Uncategorized

Dianthus Therapeutics: Go Decision For CIDP Program Warrants Continued Buy Rating

Mar 10, 2026

Biotechnology DNTH Uncategorized

Dianthus Therapeutics announces proposed $400 million public share offering

Mar 9, 2026